Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
September 20, 2024 09:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Fortinet Honored as Winner of the 2024 SC Awards for Best Professional Certification Program
September 20, 2024 09:00 ET
|
Fortinet, Inc.
SUNNYVALE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced it has been named...
The RoyaLand Company Ltd. Announces Preliminary Selected Unaudited Results for the Fiscal Year Ended June 30, 2024
September 20, 2024 09:00 ET
|
THE ROYALAND COMPANY LTD.
HAMILTON, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The RoyaLand Company Ltd. (Proposed OTC Markets Ticker: RLND) (RoyaLand), a Bermuda holding company focused on creating an online and offline...
Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis
September 20, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
September 20, 2024 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
September 20, 2024 09:00 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq...
Check Point Software is Recognized as a Leader in Email Security, Showcasing its Innovative AI-based Threat Intelligence Capabilities
September 20, 2024 09:00 ET
|
Check Point Software Technologies INC
Check Point named a Leader in Frost & Sullivan's Email Security report, celebrated for its innovative technology that provides advanced email protection.
ESGL Holdings Limited Reports First Half 2024 Financial Results
September 20, 2024 09:00 ET
|
ESGL Holdings Limited
ESGL HOLDINGS LIMITED REPORTS FIRST HALF 2024 FINANCIAL RESULTS WITH OPERATING SUBSIDIARY ACHIEVING FIRST PROFITABLE HALF YEAR
SEALSQ Integrates Internet of Payment (IoP) in Next-Generation IoT-Enabled Semiconductors, Revolutionizing Connected Commerce
September 20, 2024 08:41 ET
|
SEALSQ
Geneva, Switzerland, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum...
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
September 20, 2024 08:30 ET
|
Fortress Biotech, Inc.
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...